Cardiovascular drugs market covers the drugs used to treat conditions that affect the heart or blood vessels. These conditions include heart stroke, coronary artery diseases, valvular diseases, peripheral venous diseases, pericarditis, endocarditis, cardiac tumors, arteriosclerosis, and lymphatic diseases. Some of the major cardiovascular drugs include anti-hypertensive drugs such as calcium channel blockers and Angiotensin II receptor antagonists, and hypolipidemic drugs such as fibric acid derivatives and bile acid binding resins.

Read More: https://www.thebusinessresearchcompany.com/report/cardiovascular-drugs-global-market-report-2018

The major reasons why the global cardiovascular drugs market will increase from $130 billion in 2017 to $140 billion by 2021 are the increase in aging population, increase in the prevalence of cardiovascular diseases and availability of more generic drugs that reduce the cost of treatment.
In the report, the global cardiovascular drugs market is divided into four segments namely, anti-hypertensive drugs, other drugs for cardiovascular diseases, hypolipidemics and anti thrombotics. While the first and the second segment accounts for nearly three-fifth of the market, the remaining share is attributed to other two segments.

Sample Report: https://www.thebusinessresearchcompany.com/sample.aspx?id=250&type=smp

The USA was the largest country in the cardiovascular drugs market in 2017, accounting for nearly one-fourth of the market share. The factors attributed to the size of this market include good quality healthcare services, high healthcare expenditure, high levels of regulation and patent protection and the GDP of the country. Japan and Germany followed the USA as the next largest countries in the market.

The cardiovascular drugs market is fragmented with a number of large and
small drug organizations. The top five competitors in the market made up around 20% of the total market in 2017. Merck & Co. was the largest competitor of the market, followed by Sanofi S.A. and Pfizer Inc. Merck & Co. was founded in 1891 and is headquartered in New Jersey, USA. It offers therapeutic and preventive health solutions through prescription medicines, vaccines, biologic therapies and animal health products. Merck & Co. serves drug wholesalers and retailers, hospitals, government agencies and entities, physicians, physician distributors, veterinarians, distributors, animal producers, and managed health care providers.

About The Business Research Company.

The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.

Contact Information.

The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]